Opinion|Videos|August 5, 2024
Optimizing Multidisciplinary Care of Patients with Hidradenitis Suppurativa
Author(s)Vivian Shi, MD, FAAD
Vivian Shi, MD, FAAD, offers clinical insights on best practices for optimizing multidisciplinary care of patients with hidradenitis suppurativa.
Advertisement
Episodes in this series
Video content above is prompted by the following question:
- What are best practices for optimizing multidisciplinary care in patients with HS?
Advertisement
Related to this article
Remibrutinib (Rhapsido; Novartis) is the only treatment with approved uses in both chronic spontaneous urticaria and symptomatic dermographism.
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know if Retatrutide Is Classified as a Biologic
2
FDA Approves First Symptomatic Dermographism Treatment
3
Sacral Neuromodulation Still Seen as OAB Gold Standard in Review
4
Predoc and Nebraska Cancer Specialists: Not Letting the Fax Be the Fumble
5